Calcium, vitamin D, magnesium, vitamin K2, collagen, boron — the bone health supplement category is well-established and commercially important. It's also one of the few categories where FDA has specifically authorized health claims that mention disease risk reduction, creating a more complex claim landscape than most supplement categories.
The FDA-Authorized Calcium and Bone Health Claim
The FDA has authorized a health claim for calcium and osteoporosis under 21 CFR 101.72. This claim allows qualifying products to state that adequate calcium, as part of a well-balanced diet, may reduce the risk of osteoporosis. The claim is authorized — meaning it can use disease-risk-reduction language — but only when the product meets all qualifying criteria:
The product must contain at least 20% of the Daily Reference Value for calcium per serving (200mg)
Calcium must be in a bioavailable form
The product must not contain more phosphorus than calcium (to avoid interfering with calcium absorption)
The claim must use the specific authorized language or an equivalent that doesn't misrepresent the evidence
The claim also requires the disclaimer that adequate calcium throughout life, as part of a well-balanced diet, may reduce the risk — not that supplementation alone prevents osteoporosis.
Vitamin D was added to this authorized claim framework in subsequent FDA guidance. Products containing both calcium and vitamin D in qualifying amounts may reference both in the authorized claim.
What Qualifies as a Structure/Function Claim for Bone Health
Beyond the authorized calcium claim, structure/function claims under 21 CFR 101.93(f) for bone health include:
"Supports healthy bone density"
"Promotes healthy bone formation"
"Supports bone strength and structure"
"Helps maintain healthy bones"
"Promotes calcium absorption and bone health"
"Supports healthy bone remodeling"
"Promotes strong bones and teeth"
These are permissible when supported by evidence for the specific ingredients at the doses in your product.
Where Bone Health Claims Cross the Line
Prohibited disease claims:
"Treats osteoporosis" — osteoporosis is a named disease; treatment claims require drug approval
"Prevents bone fractures" — fracture prevention implies treatment of a disease state
"Reverses bone loss" — implies treatment of bone density disease
"For women with osteoporosis" — marketing to a diagnosed disease population
"Prevents osteopenia" — osteopenia is a precursor to osteoporosis and a named clinical condition
"Increases bone density in people with low bone mass" — low bone mass is a disease/preclinical state
The authorized calcium claim allows risk-reduction language for osteoporosis specifically because it was granted by FDA through the authorized health claim process. Using the same type of language without going through that process — or without meeting the qualifying criteria — is an unauthorized disease claim.
Vitamin K2 and Bone Claims
Vitamin K2 has emerging evidence for a role in bone health through its activation of osteocalcin. Structure/function claims about vitamin K2 supporting bone health and calcium utilization may be substantiated. Claims about vitamin K2 preventing or treating osteoporosis are not currently covered by any authorized health claim and would be prohibited disease claims.
The Collagen Connection
Bone is largely composed of type I collagen. Collagen supplements marketed for bone health sit at the intersection of the bone health and beauty supplement categories. Structure/function claims about supporting bone structure and cartilage health are potentially permissible; claims about treating bone disease are not.
Bone health is one of the few supplement categories where disease-risk-reduction claims are actually possible
But only within the strict authorized claim framework under 21 CFR 101.72 — not as general creative license. Truli scans bone health claims to distinguish between permissible structure/function claims, properly formatted authorized health claims, and prohibited osteoporosis disease claims — including marketing context that implies the product treats bone disease in populations not covered by the authorized claim.
A note from Truli: Truli is not a law firm, and this article does not constitute or contain legal advice or create an attorney-client relationship. When determining your obligations and compliance with respect to relevant laws and regulations, you should consult a licensed attorney.
